BioXcel Therapeutics, Inc. (BTAIQ): R&D Expense
$30.25M
Year ended 2025-12-31
$21.56M
Trailing 12 months to 2026-06-30
-30.8%
3-year compound annual growth
-12.2%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.25M | -0.6% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $30.43M | -63.9% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $84.33M | -7.6% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $91.24M | +73.1% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $52.71M | -9.1% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $57.99M | +124.8% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $25.80M | +77.2% | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | $14.56M | +441.2% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $2.69M | n/a | 2019-03-12, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $30.25M | -0.6% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $12.54M | -24.3% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $147.0K | +40.5% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $8.24M | +249.0% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $19.24M | -37.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $67.75M | -0.2% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.91M | -14.2% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $3.61M | +18.9% |
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $1.91M | -86.8% |
Compare BTAIQ, VCNX, ELAB, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗